phenylalanine and Cancer of Mouth

phenylalanine has been researched along with Cancer of Mouth in 27 studies

Research

Studies (27)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (14.81)	18.7374
1990's	0 (0.00)	18.2507
2000's	12 (44.44)	29.6817
2010's	10 (37.04)	24.3611
2020's	1 (3.70)	2.80

Authors

Authors	Studies
Chen, YW; Chou, FI; Lee, YJ; Lin, YC; Wang, SY	1
Iwagami, T; Iwai, S; Kato, I; Masunaga, S; Nakazawa, M; Ono, K; Sakurai, Y; Yamatomo, N; Yura, Y	1
Bauer, W; Garabalino, MA; Heber, EM; Molinari, AJ; Monti Hughes, A; Nigg, DW; Pozzi, EC; Schwint, AE; Trivillin, VA	1
Altieri, S; Aromando, RF; Bortolussi, S; Garabalino, MA; Heber, EM; Itoiz, ME; Molinari, AJ; Monti Hughes, A; Portu, AM; Pozzi, EC; Saint Martin, G; Schwint, AE; Thorp, SI; Trivillin, VA	1
Curotto, P; Molinari, AJ; Portu, A; Pozzi, EC; Saint Martin, G; Schwint, AE; Thorp, SI	1
Aromando, RF; Heber, EM; Itoiz, ME; Nigg, DW; Schwint, AE; Trivillin, VA	1
Aromando, RF; Blaumann, H; Calzetta, O; Heber, EM; Itoiz, ME; Longhino, J; Monti Hughes, A; Nievas, SI; Nigg, DW; Pozzi, E; Schwint, AE; Trivillin, VA	1
Ariyoshi, Y; Kawabata, S; Kimura, Y; Maruhashi, A; Miyatake, S; Ono, K; Shimahara, M; Suzuki, M	1
Arnopolskaya, AM; Khokhlov, VF; Kozlovskaya, NG; Kulakov, VN; Mitin, VN; Portnov, AA; Sheino, IN; Zaitsev, KN	1
Aromando, RF; Heber, EM; Itoiz, ME; Pozzi, E; Schwint, AE; Trivillin, VA	1
Chang, PY; Hsia, KT; Huang, SH; Lin, MW; Liu, CJ	1
Fujita, Y; Iwai, S; Kato, I; Ohnishi, K; Ohnishi, T; Ono, K; Sakurai, Y; Yamamoto, N; Yura, Y	1
Aromando, RF; Garabalino, MA; Heber, EM; Itoiz, ME; Miller, M; Molinari, AJ; Monti Hughes, A; Nigg, DW; Pozzi, EC; Schwint, AE; Thorp, S; Trivillin, VA	1
Aromando, RF; Garabalino, MA; Heber, EM; Itoiz, ME; Miller, M; Molinari, AJ; Monti Hughes, A; Nigg, DW; Pozzi, EC; Schwint, AE; Thorp, SI; Trivillin, VA	1
Chang, CW; Chou, FI; Hsiao, MC; Hwang, JJ; Lin, YC; Wang, SJ; Yang, BH	1
Batistoni, D; Heber, E; Itoiz, ME; Kreimann, EL; Nigg, D; Rebagliati, RJ; Schwint, AE; Trivillin, VA	1
Kato, I; Masunaga, S; Nagata, K; Obayashi, S; Ono, K; Sakurai, Y; Suzuki, M; Yura, Y	1
Blaumann, H; Calzetta, O; Heber, EM; Itoiz, ME; Longhino, J; Nigg, D; Schwint, AE; Trivillin, VA	1
Kamida, A; Kato, I; Nagata, K; Obayashi, S; Ono, K; Sakurai, Y; Suzuki, M; Yura, Y	1
Batistoni, D; Gonzalez, BN; Heber, EM; Itoiz, ME; Kreimann, EL; Nigg, DW; Rebagliati, RJ; Schwint, AE; Trivillin, VA	1
Fujita, Y; Iwai, S; Kamida, A; Kato, I; Ono, K; Sakurai, Y; Suzuki, M; Yura, Y	1
Blaumann, H; Calzetta, O; Itoiz, ME; Kreimann, EL; Longhino, J; Schwint, AE	1
Batistoni, D; Dagrosa, A; Farías, S; Garavaglia, R; Itoiz, ME; Kreimann, EL; Schwint, AE	1
Chorazy, M; Filipski, J; Marczyński, B	1
Cukor, G; Kuchler, RJ; Solotorovsky, M	1
Daluge, S; Palm, M; Vince, R	1
Lembach, KJ; Taylor, JM	1

Other Studies

27 other study(ies) available for phenylalanine and Cancer of Mouth

Article	Year
Evaluation of the Key Advantages between Two Modalities of Boronophenylalanine Administration for Clinical Boron Neutron Capture Therapy Using an Animal Model. Cells, 2022, 09-01, Volume: 11, Issue:17 Topics: Animals; Boron; Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Carcinoma, Squamous Cell; Disease Models, Animal; Humans; Mouth Neoplasms; Phenylalanine	2022
Sonoporation as an enhancing method for boron neutron capture therapy for squamous cell carcinomas. Radiation oncology (London, England), 2013, Dec-02, Volume: 8 Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Membrane; Female; Humans; Isotopes; Mice; Mice, Inbred BALB C; Mice, Nude; Microbubbles; Mouth Neoplasms; Neoplasm Transplantation; Neutrons; Phenylalanine; Radiotherapy; Ultrasonics	2013
Boron biodistribution for BNCT in the hamster cheek pouch oral cancer model: combined administration of BSH and BPA. Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2014, Volume: 88 Topics: Animals; Borohydrides; Boron Compounds; Boron Neutron Capture Therapy; Cheek; Cricetinae; Drug Combinations; Mesocricetus; Metabolic Clearance Rate; Mouth Neoplasms; Organ Specificity; Phenylalanine; Radiotherapy Dosage; Sulfhydryl Compounds; Tissue Distribution; Treatment Outcome	2014
Assessing advantages of sequential boron neutron capture therapy (BNCT) in an oral cancer model with normalized blood vessels. Acta oncologica (Stockholm, Sweden), 2015, Volume: 54, Issue:1 Topics: 9,10-Dimethyl-1,2-benzanthracene; Angiogenesis Inhibitors; Animals; Boron Compounds; Boron Neutron Capture Therapy; Carcinogens; Cricetinae; Mesocricetus; Mouth Neoplasms; Neovascularization, Pathologic; Phenylalanine; Precancerous Conditions; Thalidomide	2015
Neutron autoradiography to study boron compound microdistribution in an oral cancer model. International journal of radiation biology, 2015, Volume: 91, Issue:4 Topics: Animals; Autoradiography; Boron Compounds; Boron Neutron Capture Therapy; Cricetinae; Humans; Mesocricetus; Mouth Neoplasms; Phenylalanine; Tissue Distribution	2015
Insight into the mechanisms underlying tumor response to boron neutron capture therapy in the hamster cheek pouch oral cancer model. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2009, Volume: 38, Issue:5 Topics: Animals; Apoptosis; Boron Compounds; Boron Neutron Capture Therapy; Cheek; Cricetinae; Disease Models, Animal; DNA, Neoplasm; Drug Carriers; In Situ Nick-End Labeling; Mesocricetus; Mouth Neoplasms; Neoplasms, Experimental; Phenylalanine; Radiation Dosage; Radiation-Sensitizing Agents; Radiopharmaceuticals	2009
Boron neutron capture therapy (BNCT) inhibits tumor development from precancerous tissue: an experimental study that supports a potential new application of BNCT. Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2009, Volume: 67, Issue:7-8 Suppl Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Borohydrides; Boron Compounds; Boron Neutron Capture Therapy; Cricetinae; Mouth Neoplasms; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Phenylalanine; Precancerous Conditions; Radiation-Sensitizing Agents; Sulfhydryl Compounds; Tissue Distribution	2009
Boron neutron capture therapy for recurrent oral cancer and metastasis of cervical lymph node. Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2009, Volume: 67, Issue:7-8 Suppl Topics: Adult; Aged; Aged, 80 and over; Boron Compounds; Boron Neutron Capture Therapy; Female; Fluorine Radioisotopes; Humans; Lymphatic Metastasis; Male; Middle Aged; Mouth Neoplasms; Neck; Neoplasm Recurrence, Local; Pain; Phenylalanine; Positron-Emission Tomography; Quality of Life; Radiation-Sensitizing Agents; Radiopharmaceuticals; Tomography, X-Ray Computed	2009
Comparison of BNCT and GdNCT efficacy in treatment of canine cancer. Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2009, Volume: 67, Issue:7-8 Suppl Topics: Animals; Bone Neoplasms; Boron Compounds; Boron Neutron Capture Therapy; Combined Modality Therapy; Dog Diseases; Dogs; Gadolinium; Humans; Melanoma; Mouth Neoplasms; Neoplasms; Neutron Capture Therapy; Osteosarcoma; Phenylalanine	2009
Early effect of boron neutron capture therapy mediated by boronophenylalanine (BPA-BNCT) on mast cells in premalignant tissue and tumors of the hamster cheek pouch. Oral oncology, 2010, Volume: 46, Issue:5 Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Cell Count; Cell Line, Tumor; Cell Proliferation; Cheek; Cricetinae; Mast Cells; Mouth Neoplasms; Phenylalanine; Precancerous Conditions; Radiation-Sensitizing Agents	2010
O6-methylguanine-DNA methyltransferase gene coding region polymorphisms and oral cancer risk. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2010, Volume: 39, Issue:8 Topics: Age Factors; Carcinoma, Squamous Cell; Case-Control Studies; Codon; Cytosine; Disease-Free Survival; Female; Gene Frequency; Genetic Predisposition to Disease; Genetic Variation; Genotype; Haplotypes; Humans; Leucine; Linkage Disequilibrium; Male; Middle Aged; Mouth Neoplasms; O(6)-Methylguanine-DNA Methyltransferase; Phenylalanine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Precancerous Conditions; Retrospective Studies; Risk Factors; Sequence Analysis, DNA; Survival Rate; Taiwan; Thymine	2010
Induction of multinucleation in oral squamous cell carcinoma tissue with mutated p53 surviving boron neutron capture therapy. International journal of radiation biology, 2011, Volume: 87, Issue:3 Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Female; Genes, p53; Mice; Mice, Inbred BALB C; Mice, Nude; Mitosis; Mouth Neoplasms; Mutation; Neoplasm Transplantation; Phenotype; Phenylalanine; Radiation-Sensitizing Agents	2011
Boron Neutron Capture Therapy (BNCT) in an oral precancer model: therapeutic benefits and potential toxicity of a double application of BNCT with a six-week interval. Oral oncology, 2011, Volume: 47, Issue:11 Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Cheek; Cricetinae; Disease Models, Animal; DNA; Mouth Neoplasms; Mucositis; Phenylalanine; Precancerous Conditions; Radiation Injuries, Experimental; Treatment Outcome	2011
Tumor blood vessel "normalization" improves the therapeutic efficacy of boron neutron capture therapy (BNCT) in experimental oral cancer. Radiation research, 2012, Volume: 177, Issue:1 Topics: Angiogenesis Inhibitors; Animals; Blood Vessels; Boron Compounds; Boron Neutron Capture Therapy; Cheek; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Radiation; Mouth Neoplasms; Phenylalanine; Thalidomide; Treatment Outcome	2012
Macro- and microdistributions of boron drug for boron neutron capture therapy in an animal model. Anticancer research, 2012, Volume: 32, Issue:7 Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Cell Line, Tumor; Fluorine Radioisotopes; Fructose; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Mouth Neoplasms; Phenylalanine; Positron-Emission Tomography; Xenograft Model Antitumor Assays	2012
Biodistribution of GB-10 (Na(2)(10)B10H10 compound for boron neutron capture therapy (BNCT) in an experimental model of oral cancer in the hamster cheek pouch. Archives of oral biology, 2004, Volume: 49, Issue:4 Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Cheek; Cricetinae; Drug Combinations; Drug Interactions; Models, Animal; Mouth Neoplasms; Phenylalanine; Precancerous Conditions; Radiation-Sensitizing Agents	2004
Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy. Oral oncology, 2004, Volume: 40, Issue:5 Topics: Animals; Borohydrides; Boron; Boron Compounds; Boron Neutron Capture Therapy; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Survival; Female; Isotopes; Mice; Mice, Nude; Mouth Neoplasms; Phenylalanine; Relative Biological Effectiveness; Sulfhydryl Compounds	2004
Radiobiology of BNCT mediated by GB-10 and GB-10+BPA in experimental oral cancer. Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2004, Volume: 61, Issue:5 Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Cheek; Cricetinae; Mouth Neoplasms; Phenylalanine; Radiotherapy Dosage	2004
Effects of boron neutron capture therapy on human oral squamous cell carcinoma in a nude mouse model. International journal of radiation biology, 2006, Volume: 82, Issue:1 Topics: Animals; Apoptosis; Body Weight; Boron Compounds; Boron Neutron Capture Therapy; Bromodeoxyuridine; Carcinoma, Squamous Cell; Female; Humans; Immunohistochemistry; Mice; Mice, Inbred BALB C; Mice, Nude; Mouth Neoplasms; Neoplasm Transplantation; Phenylalanine; Transplantation, Heterologous	2006
Homogeneous boron targeting of heterogeneous tumors for boron neutron capture therapy (BNCT): chemical analyses in the hamster cheek pouch oral cancer model. Archives of oral biology, 2006, Volume: 51, Issue:10 Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Borohydrides; Boron Compounds; Boron Neutron Capture Therapy; Cheek; Cricetinae; Disease Models, Animal; Mesocricetus; Mouth Mucosa; Mouth Neoplasms; Phenylalanine; Precancerous Conditions	2006
Effect of neutron capture therapy on the cell cycle of human squamous cell carcinoma cells. International journal of radiation biology, 2008, Volume: 84, Issue:3 Topics: Boron Compounds; Boron Neutron Capture Therapy; Carcinoma, Squamous Cell; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Survival; Humans; Mouth Neoplasms; Phenylalanine; Tumor Suppressor Protein p53	2008
Boron neutron capture therapy for the treatment of oral cancer in the hamster cheek pouch model. Cancer research, 2001, Dec-15, Volume: 61, Issue:24 Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Boron Compounds; Boron Neutron Capture Therapy; Carcinogens; Cheek; Cricetinae; Disease Models, Animal; Mesocricetus; Mouth Neoplasms; Phenylalanine; Precancerous Conditions; Radiation-Sensitizing Agents	2001
The hamster cheek pouch as a model of oral cancer for boron neutron capture therapy studies: selective delivery of boron by boronophenylalanine. Cancer research, 2001, Dec-15, Volume: 61, Issue:24 Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Boron; Boron Compounds; Boron Neutron Capture Therapy; Carcinogens; Cheek; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Injections, Intravenous; Injections, Subcutaneous; Mesocricetus; Mouth Neoplasms; Phenylalanine; Radiation-Sensitizing Agents; Tissue Distribution	2001
Complexes of derivatives of 1-nitro-9-aminoacridine with DNA. Acta biochimica Polonica, 1975, Volume: 22, Issue:2 Topics: Acridines; Aminacrine; Amines; Binding Sites; Carbon Radioisotopes; Carcinoma; Cations, Divalent; Cations, Monovalent; Cell Line; Cells, Cultured; Chemical Phenomena; Chemistry; Depression, Chemical; DNA; Humans; Hydrogen-Ion Concentration; Mouth Neoplasms; Nitro Compounds; Nucleic Acid Denaturation; Phenylalanine; Protein Biosynthesis; RNA; Spectrum Analysis; Structure-Activity Relationship; Transcription, Genetic; Tritium; Uridine	1975
Biological activity of heated diphtheria toxin. Journal of bacteriology, 1973, Volume: 115, Issue:1 Topics: Animals; Carbon Isotopes; Carcinoma; Cell Line; Cell-Free System; Corynebacterium diphtheriae; Diphtheria Toxin; Electrophoresis, Polyacrylamide Gel; HeLa Cells; Hot Temperature; Humans; Hydrogen-Ion Concentration; L Cells; Liver; Mice; Molecular Weight; Mouth Neoplasms; Neoplasm Proteins; Ornithine; Phenylalanine; Polymers; Protein Biosynthesis; Rats; Ribosomes	1973
Inhibition of in vitro protein synthesis by a carbocyclic puromycin analog. Biochemical and biophysical research communications, 1972, Jan-31, Volume: 46, Issue:2 Topics: Animals; Antineoplastic Agents; Bacterial Proteins; Carbon Isotopes; Carcinoma; Cell Line; Chloramphenicol; Cytosine Nucleotides; Depression, Chemical; Escherichia coli; Leukemia; Leukemia L1210; Mouth Neoplasms; Peptide Biosynthesis; Phenylalanine; Polynucleotides; Puromycin; Ribosomes; Stereoisomerism; Uracil Nucleotides	1972
Reversible inhibition of cell multiplication in vitro by inhibitors of arginine esteroproteases. Biochimica et biophysica acta, 1973, Nov-02, Volume: 329, Issue:1 Topics: Adenine; Amidines; Aniline Compounds; Animals; Arginine; Benzene Derivatives; Carcinoma; Cell Division; Cell Line; DNA; Fibroblasts; Humans; Ketones; L Cells; Lysine; Mice; Mitochondria, Liver; Mouth Neoplasms; Oxidative Phosphorylation; Phenylalanine; Protease Inhibitors; RNA; Tosyl Compounds; Trypsin Inhibitors	1973